Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £1 | £1 | £1 | £1 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £1 | £1 | £1 | £1 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | £0 | £0 | £0 | £0 |
| % Margin | 7.1% | 14.4% | 18.1% | 25.1% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | £0 | £0 | £0 | £0 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46.2% | -27.8% | – |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |